198 related articles for article (PubMed ID: 19135426)
1. PPARgamma agonist pioglitazone reduces matrix metalloproteinase-9 activity and neuronal damage after focal cerebral ischemia.
Lee SR; Kim HY; Hong JS; Baek WK; Park JW
Biochem Biophys Res Commun; 2009 Feb; 380(1):17-21. PubMed ID: 19135426
[TBL] [Abstract][Full Text] [Related]
2. PPARgamma agonist pioglitazone reduces [corrected] neuronal cell damage after transient global cerebral ischemia through matrix metalloproteinase inhibition.
Lee KJ; Jang YH; Lee H; Yoo HS; Lee SR
Eur J Neurosci; 2008 Jan; 27(2):334-42. PubMed ID: 18215232
[TBL] [Abstract][Full Text] [Related]
3. Doxycycline inhibits matrix metalloproteinase-9 and laminin degradation after transient global cerebral ischemia.
Lee H; Park JW; Kim SP; Lo EH; Lee SR
Neurobiol Dis; 2009 May; 34(2):189-98. PubMed ID: 19200854
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.
Zhang HL; Xu M; Wei C; Qin AP; Liu CF; Hong LZ; Zhao XY; Liu J; Qin ZH
Neuroscience; 2011 Mar; 176():381-95. PubMed ID: 21185913
[TBL] [Abstract][Full Text] [Related]
5. The intracerebral application of the PPARgamma-ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain.
Zhao Y; Patzer A; Gohlke P; Herdegen T; Culman J
Eur J Neurosci; 2005 Jul; 22(1):278-82. PubMed ID: 16029218
[TBL] [Abstract][Full Text] [Related]
6. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats.
Cao Z; Ye P; Long C; Chen K; Li X; Wang H
Pharmacology; 2007; 79(3):184-92. PubMed ID: 17356310
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptorsgamma (PPARgamma) differently modulate the interleukin-6 expression in the peri-infarct cortical tissue in the acute and delayed phases of cerebral ischaemia.
Patzer A; Zhao Y; Stöck I; Gohlke P; Herdegen T; Culman J
Eur J Neurosci; 2008 Nov; 28(9):1786-94. PubMed ID: 18973594
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of quercetin, a natural flavonoid against neuronal damage after transient global cerebral ischemia.
Cho JY; Kim IS; Jang YH; Kim AR; Lee SR
Neurosci Lett; 2006 Sep; 404(3):330-5. PubMed ID: 16806698
[TBL] [Abstract][Full Text] [Related]
9. Green tea polyphenol (-)-epigallocatechin gallate reduces neuronal cell damage and up-regulation of MMP-9 activity in hippocampal CA1 and CA2 areas following transient global cerebral ischemia.
Park JW; Jang YH; Kim JM; Lee H; Park WK; Lim MB; Chu YK; Lo EH; Lee SR
J Neurosci Res; 2009 Feb; 87(2):567-75. PubMed ID: 18752302
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effect of pioglitazone on acute phase changes induced by partial global cerebral ischemia in mice.
Medhi B; Aggarwal R; Chakrabarti A
Indian J Exp Biol; 2010 Aug; 48(8):793-9. PubMed ID: 21341537
[TBL] [Abstract][Full Text] [Related]
11. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.
Asahi M; Asahi K; Jung JC; del Zoppo GJ; Fini ME; Lo EH
J Cereb Blood Flow Metab; 2000 Dec; 20(12):1681-9. PubMed ID: 11129784
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia-reperfusion injury in mice with metabolic disorders.
Honda T; Kaikita K; Tsujita K; Hayasaki T; Matsukawa M; Fuchigami S; Sugiyama S; Sakashita N; Ogawa H; Takeya M
J Mol Cell Cardiol; 2008 May; 44(5):915-26. PubMed ID: 18436235
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
[TBL] [Abstract][Full Text] [Related]
14. Activation of cerebral peroxisome proliferator-activated receptors γ (PPARγ) reduces neuronal damage in the substantia nigra after transient focal cerebral ischaemia in the rat.
Zuhayra M; Zhao Y; von Forstner C; Henze E; Gohlke P; Culman J; Lützen U
Neuropathol Appl Neurobiol; 2011 Dec; 37(7):738-52. PubMed ID: 21366664
[TBL] [Abstract][Full Text] [Related]
15. Neuronal expression of peroxisome proliferator-activated receptor-gamma (PPARgamma) and 15d-prostaglandin J2--mediated protection of brain after experimental cerebral ischemia in rat.
Ou Z; Zhao X; Labiche LA; Strong R; Grotta JC; Herrmann O; Aronowski J
Brain Res; 2006 Jun; 1096(1):196-203. PubMed ID: 16725118
[TBL] [Abstract][Full Text] [Related]
16. Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats.
Zhao Y; Patzer A; Herdegen T; Gohlke P; Culman J
FASEB J; 2006 Jun; 20(8):1162-75. PubMed ID: 16770015
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of prostaglandin A(1) in rat models of permanent focal cerebral ischemia are associated with nuclear factor-kappaB inhibition and peroxisome proliferator-activated receptor-gamma up-regulation.
Zhang HL; Gu ZL; Savitz SI; Han F; Fukunaga K; Qin ZH
J Neurosci Res; 2008 Apr; 86(5):1132-41. PubMed ID: 18074385
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment.
Grommes C; Landreth GE; Sastre M; Beck M; Feinstein DL; Jacobs AH; Schlegel U; Heneka MT
Mol Pharmacol; 2006 Nov; 70(5):1524-33. PubMed ID: 16887936
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, reduces the progression of experimental osteoarthritis in guinea pigs.
Kobayashi T; Notoya K; Naito T; Unno S; Nakamura A; Martel-Pelletier J; Pelletier JP
Arthritis Rheum; 2005 Feb; 52(2):479-87. PubMed ID: 15692987
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts.
Zafiriou S; Stanners SR; Saad S; Polhill TS; Poronnik P; Pollock CA
J Am Soc Nephrol; 2005 Mar; 16(3):638-45. PubMed ID: 15689403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
